FDA Law Blog: Biosimilars

DECEMBER 4, 2023

Within one month of each comprehensive review, the pharmacy must prepare a written report identifying prescriptions filled that were not issued for a legitimate medical purpose or filled outside the usual course of the professional practice of pharmacy, and prescriptions in violation of the permanent injunction terms.

Controlled Substances 139

Controlled Substances Documentation Dosage Prescription Filling 139

Proxsys Rx

DECEMBER 8, 2022

Before a TPA can provide your health system with support, your data team must automate a data feed from your EHR to your TPA — one which documents 340B-eligible patient encounters. 340B program support fee structures In general, you should avoid TPAs that charge fees for every pharmacy prescription fill they assess.

Prescription Filling 52

Prescription Filling Hospitals Documentation 52

National Association of Boards of Pharmacy

MAY 6, 2022

California: A law passed in September 2021 prohibits using “metrics,” like a quota on number of prescriptions filled, to evaluate a pharmacist’s productivity. We also signed onto APhA’s and the National Alliance of State Pharmacy Associations’ Pharmacist’s Fundamental Responsibilities and Rights document.

Mayo Clinic 40

Mayo Clinic Pharmacy Technician Prescription Filling Documentation 40

Ramblings of a pharmacist

FEBRUARY 16, 2022

It’s a well-thought through survey document, but I still have uncertainties about how to answer some of the questions – a part asks how many prescriptions were filled with brands and how many with generics. prescription transaction. (If It’s an invaluable document, even if it isn’t perfect.

Independent Pharmacies 52

Independent Pharmacies Compounding Specialty Pharmacies Prescription Filling 52

Putting Patients First Blog

SEPTEMBER 3, 2024

We recommend that CMS offer more specific sub-questions, similar to other questions in the document, aimed at prioritizing the identification of health disparities that may affect access to and outcomes from the selected drug. Prior authorization and association with delayed or discontinued prescription fills. and Keating, N.

Drug Pricing 52

Drug Pricing Insurance Coverage and Processing Labelling Communication 52

Putting Patients First Blog

JULY 2, 2024

The NHC requests more clarity on how CMS will exclude QALY-based metrics and highlight when they have been removed from consideration in MFP justification documentation. Prior authorization and association with delayed or discontinued prescription fills. and Keating, N. Journal of Clinical Oncology, 42(8). link] xii Chino, F.,

Drug Pricing 52

Drug Pricing Insurance Coverage and Processing Labelling HIPAA 52